Biotech | August 07, 2021
Sanofi to acquire Translate Bio
Advances deployment of mRNA technology across vaccines and therapeutics development
Advances deployment of mRNA technology across vaccines and therapeutics development
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Production line at Lonza’s site in Geleen will complement the existing production network and support the manufacture of up to an additional 300 million doses per year
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
Subscribe To Our Newsletter & Stay Updated
